Advertisement
Canada markets open in 5 hours 42 minutes

  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CAD/USD

    0.7300
    -0.0001 (-0.01%)
     

  • CRUDE OIL

    82.42
    +0.52 (+0.63%)
     

  • Bitcoin CAD

    90,673.66
    +82.62 (+0.09%)
     

  • CMC Crypto 200

    1,396.35
    -18.41 (-1.30%)
     

  • GOLD FUTURES

    2,324.10
    -22.30 (-0.95%)
     

  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     

  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     

  • NASDAQ futures

    17,359.00
    +9.00 (+0.05%)
     

  • VOLATILITY

    16.67
    -0.27 (-1.59%)
     

  • FTSE

    8,058.63
    +34.76 (+0.43%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6833
    -0.0017 (-0.25%)
     

AstraZeneca scours supply chain for more vaccine doses for Thailand, SE Asia

Reuters
·2 min read
COVID-19 vaccinations in Bangkok

BANGKOK (Reuters) - AstraZeneca Plc is "scouring" its global supply chain to try and boost COVID-19 vaccine supplies to Thailand and Southeast Asia, its representative for the country said on Saturday, amidst speculations of local production shortfalls.

The comments come after leaked letters https://www.reuters.com/business/healthcare-pharmaceuticals/leaked-letters-show-astrazeneca-vaccine-commitment-not-thailand-claimed-2021-07-19 showed last week that the drugmaker had offered to supply 5-6 million vaccine doses a month to Thailand, contradicting assertions by Thai officials that the government is owed 10 million a month and 61 million doses by end-2021.

AstraZeneca is "scouring the 20+ supply chains in our worldwide manufacturing network to find additional vaccines for Southeast Asia, including Thailand", James Teague, managing director of AstraZeneca Thailand, said in a statement.

"We are hopeful of importing additional doses in the months ahead," he added.

ADVERTISEMENT

The drugmaker had previously said vaccine doses for Thailand and Southeast Asia would come from a plant of its Thai partner Siam Bioscience, owned by Thailand's king and a first-time vaccine maker.

Pressure has been mounting on the company after Thailand said it was considering imposing limits https://www.reuters.com/world/asia-pacific/thailand-considering-regulating-volume-astrazeneca-vaccine-exports-health-2021-07-14 on exports of locally manufactured AstraZeneca COVID-19 vaccines to shore up domestic supplies, a move that could hit its neighbours, some of which are battling similar or more severe COVID-19 crises.

Siam Bioscience has not commented on reports of production shortfalls or delivery timelines.

Teague said AstraZeneca has delivered 9 million does so far to Thailand and will deliver 2.3 million more next week.

Thailand has fully inoculated just 5.56% of its population of more than 66 million so far, while 18.62% have received at least one dose, government data shows.

(Reporting by Patpicha Tanakasempipat; Editing by Kay Johnson and Himani Sarkar)